Objective: Accelerated atherosclerosis is associated with herpesviral infection both in transplant patients and after balloon angioplasty.
Introduction
Rapid growth of atherosclerotic plaque occurs in two w x settings, after cardiac transplantation 1-3 and after angiow x plasty of stenotic coronary arteries 4,5 . Viral infection has been implicated in plaque development in both setw x tings, after transplant 6-9 and after balloon mediated w x arterial injury 10,11 . Increased titers of antigenic markers Ž . w x for the herpesviruses, Cytomegalovirus CMV 9 and Ž . w x Herpes Simplex virus HSV 12 , have been detected in smooth muscle cells at sites of de novo atherosclerotic w x plaque growth [13] [14] [15] [16] . CMV infection has also been correlated with plaque development in transplant vascuw x lopathy 6-9 . Viral antigens and DNA have been detected w x by immunohistochemical analysis 13,14 , in situ hyw x bridization 13-15 , and more recently by PCR analysis w x 15,16 in atherosclerotic arterial extracts. CMV expression has also been associated with decreased expression of a tumor suppresser gene, p53, in areas of recurrent athero-Ž . sclerotic plaque growth restenosis after angioplasty w x 10,11 .
Infection of newborn chicks with an avian gamma Ž .
herpesvirus, Marek's Disease virus MDV , induces both
Time for primary review 35 days.
0008-6363r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved. an invasive T cell lymphoma and atherosclerosis development in the thoracic aorta and larger arterial branches w x 17-19 . The precise mechanisms by which MDV and other herpesviruses initiate plaque growth, however, are not known. Damage induced by viral infection, altered w x cellular metabolism, direct cellular transformation 18,20 , and inflammatory and immune reactions to viral infection w x may accelerate plaque development [18] [19] [20] [21] [22] . MDV viral antigens have been detected in the arterial wall indicating viral infection of vascular cells and MDV has also been reported to increase smooth muscle cellular cholesterol w x levels in tissue culture 21 . MDV infection is associated with diffuse pervasive lymphocytic infiltrates which may increase vessel damage and initiate plaque growth. CMV infection of arterial smooth muscle cells has been detected in rats and is associated with increased mononuclear cell adhesion and invasion into the vascular endothelium w x 20,22 . Cellular invasion in CMV infections is enhanced w x by high serum cholesterol levels 20,22 . Monocyte and Ž . lymphocyte specifically T cell activation and invasion are associated with plaque development in animal models w x of balloon injury and hyperlipidemia 4,23-25 , but the role of lymphocyte invasion in herpesvirus, and specifically Marek's disease virus, associated atherosclerosis is not known.
The objective of this study was to assess the effects of the HMGCoA reductase inhibitor, pravastatin, and the ACE inhibitor, quinapril, on atherosclerotic plaque growth and lymphocyte invasion induced by MDV infection and w hypercholesterolemia. HMGCoA reductase inhibitors 26-x w x 30 and ACE inhibitors 31-34 have been proven to reduce cardiovascular events in clinical trials. Both drugs decrease balloon injury induced atherosclerosis in animal w x models 35-42 , but neither agent has demonstrated effiw x cacy for prevention of restenosis in clinical studies 43-46 . HMGCoA reductase inhibitors do, however, reduce corow x nary vasculopathy post transplant 30 and preliminary studies with ACE inhibitors also suggest benefit in transplant vasculopathy, suggesting possible efficacy in virus associated atherosclerosis development. Both HMGCoA reductase and ACE inhibitors have also been reported to alter monocytic cell invasion, but effects on lymphocyte infiltration in the arterial wall have not been extensively studied. There have been no prior studies on the effects of current therapeutic approaches on virus-induced accelerated atherosclerosis or vascular lymphocytic infiltrates, either in the clinical setting or in animal models.
Methods

Marek's disease Õirus infection
Ž
. In total 120 new born chicks one day old were inoculated with 500 cfu of the MD5 strain of Marek's Ž disease virus American Type Culture Collection Atlanta, . Georgia ; 250 cfu via intratracheal inoculation and 250 cfu w x via intraperitoneal injection 47 . In Study 1 the effects of pravastatin on virus-induced plaque growth were assessed Ž . in 60 chicks on normal ND-30 chicks and 2% cholesterol Ž . in 10% peanut oil CD-30 chicks diets. After 90 days each Ž . group ND or CD of surviving chicks was further divided into groups for treatment with either pravastatin or saline. In Study 2, chicks were maintained on CD for the duration of the study. At 90 days post infection the surviving chicks in Study 2 were divided into three groups for treatment with pravastatin, quinapril, or saline control.
In both studies, MDV infected chicks were followed after treatment was started until premature death secondary to lymphoma or to a total follow up period of 180 days post MDV infection. Chicks were monitored for signs of paralysis, decreased feeding, or generalized weakness and sacrificed early if demonstrating signs of distress. Fresh MDV isolates from the American Type culture collection were used for both studies to avoid potential altered virulence due to passage of the virus in tissue culture.
Treatment of Marek's disease Õirus infected chicks with praÕastatin or quinapril
Study 1: of the 60 MDV infected chicks, 14 ND chicks and 12 CD chicks died secondary to MDV induced lym-Ž . phoma within three months p s 0.60 . At three months post infection, surviving chicks were started on pravastatin ŽBristol Myers Squibb Pharmaceutical Research, Montreal, . Ž . Quebec at 0.8 mgrkgrday orally or placebo saline and Ž followed for three months 8 ND chicks treated with pravastatin, 8 ND chicks treated with saline, 11 CD chicks treated with pravastatin, and 7 CD chicks treated with . saline . Pravastatin or saline was given on a daily basis in a 0.25 ml saline suspension administered orally via dropper.
Study 2: 16r60 MDV infected rooster chicks died prior to the starting date for treatment. At 90 days, the 44 rooster chicks surviving the MDV infection were started on one of three treatment regimes given orally by dropper Ž . daily as follows; 0.25 ml saline 14 roosters , 0.8 mg Ž . pravastatin per kg bird weight in 0.25 ml 15 roosters , and Ž 0.8 mg per kg bird weight quinapril Parke Davis, Ann . Ž . Arbor, Michigan in 0.25 ml 15 roosters . After 21 days increased mortality was noted in the quinapril group and the dose of quinapril was subsequently reduced to 0.08 mg per kg body weight per bird. Chicks were weighed twice weekly and the dose adjusted according to weight.
General animal care
The chicks were maintained in a biohazard containment facility and were treated according to the guidelines of the 
Histological and morphometric analysis
In Study 1, aortic specimens from three areas were excised and formalin fixed: the thoracic aorta from the left subclavian artery to the coeliac axis, the abdominal aorta from the coeliac axis to the iliac arteries, and the carotid arteries. In Study 2 the femoral arteries were examined in place of the abdominal aorta due to the fact that more atherosclerotic plaque growth was detected in the thoracic aorta and large aortic branches than in the abdominal aorta in Study 1. In Study 2, specimens were also taken from the heart, liver, spleen, and femoral nerve for histological analysis in order to assess the extent of MDV induced lymphoma.
A total of 82 arterial sections and 20 myocardial specimens for Study 1 and 192 arterial, 21 myocardial, 21 kidney, 26 liver, and 20 femoral nerve specimens for Study 2 were harvested for histological analysis. Speci-Ž . mens were fixed in 0.10 vrv sodium phosphate buffered formalin, processed, impregnated and embedded in paraffin and cut into 5 mm sections by microtome as has been w x previously described 48 . Sections were then stained with hematoxylin and eosin and examined by light microscopy. In Study 1, 14 sections were taken from each of the arterial specimens and 4 sections were cut from the myocardial specimens. In Study 2, 4 sections from each arterial and organ specimen were stained. The section with the largest plaque was used for morphometric analysis of the plaque area and thickness in each study. The mean area for the arterial sections taken from each bird was calculated and used for subsequent statistical analyses. All specimens, arterial and other, were independently examined by a veterinary pathologist, blinded to treatment, for evidence of MDV infection induced lymphocytic cell infiltrates and atheromatous plaque development. The MDV associated changes were graded on a scale of 0-3 by the pathologist based upon the degree of lymphoma related cellular infiltration and proliferation.
Initially intimal area and thickness were measured with a Nikon Optiphot-Labophot drawing device attached to a Ž Nikon Labophot-2 model light microscope Nikon, Nippon . Kogaku K.K., Tokyo Japan . Plaque area was then measured with a Jandell Scientific Sigma Scan program and a digitizing Summa sketch pad coupled to a MacIntosh IIcx Ž . computer MacMeasure software as previously described w x 47,48 . Later measurements were made with a Sony Power HAD 3CCD color video camera attached to a Zeiss Axioskop connected to the Empix Northern Eclipse trace Ž application program Empix Imaging Inc., Mississauga, . Ontario . Each system was calibrated to the microscopic objective. Only one system was used for each series of measurements to avoid variability inherent in individual morphometric systems. In Study 2, both morphometric analysis systems were used for comparative purposes. The Ž presence and area of lymphocytic and foam cell vacuo-. lated fat filled cells infiltrates into the intima, media and adventitia were also noted and measured using this morphometric system. Fibrosis, thrombosis and calcification were not seen and were not measured in these studies. Intimal thickness was also measured by ocular micrometer.
Serum cholesterol
Serum and arterial cholesterol levels were measured in each group in Study 1 where chicks on normal diet and high cholesterol diet were assessed after treatment with either control saline or pravastatin. Cholesterol was mea-Ž sured using standard cholesterol assay kits Sigma Chemi-. w x cal as previously described 48,49 .
Statistics
The significance of measured differences in plaque area, plaque thickness, and cellular infiltrates on morphometric analysis were assessed by analysis of variance Ž . ANOVA and Student's t test analysis after drug treatment and on each dietary regimen. The mean for all plaque area and thickness measurements for individual birds in each study was calculated. The mean values for the measurements on each rooster were used for all subsequent statistical analyses. Differences in survival and potential correlations between length of treatment andror survival time after treatment was assessed within treatment groups by Kaplan Meier survival analysis as well as Logrank and Chi square analysis. after pravastatin treatment in the cholesterol fed rooster Ž . chicks Fig. 1C but not in pravastatin treated chicks on Ž . normal diets Fig. 2A . Plaque thickness was measured as 0.046 " 0.011 mm and 0.013 " 0.005 mm respectively after control saline and pravastatin treatment for choles-Ž . terol fed chicks p -0.03 and 0.029 " 0.011 mm and 0.025 " 0.008 mm respectively after control saline and pravastatin treatment for chicks on normal diet. A significant reduction in intimal area was also observed in Study 2 with pravastatin treatment and with quinapril treatment Ž . Ž . Fig. 1D after two months of treatment Fig. 2A, B .
Results
Atherosclerotic plaque deÕelopment in MDV infected chicks
The
. 1B . More fatty intimal hyperplasia was detected in the carotid arterial specimens than in the thoracic aorta. Minimal plaque growth was detectable in the abdominal aorta. Thrombosis, fibrosis, and calcification were not detected in this study. There is intimal hyperplasia and cellular infiltration visible in the MDV infected birds after less than 60 days of treatment but the differences in intimal hyperplasia are much less pronounced and did not reach significance for this shorter treatment time for either pravastatin or quinapril on comparison with the controls. The greatest decrease in plaque area is seen after 60 days treatment Ž . Fig. 2B , p -0.001 . No significant reduction in intimal area was detected in chicks treated for less than 60 days Ž . with either drug p s 0.87 by ANOVA . There was no statistically significant difference between the plaque area Ž measured in chicks treated for less than one month 0.363 2 . " 0.107 mm on comparison with arterial specimens taken from chicks that died prior to starting treatment Ž 2 . 0.467 " 0.143 mm , p s 0.22 indicating that the two drugs had minimal effect on plaque growth after less than 30 days treatment.
MDV associated lymphocytic cell infiltrates in the arterial wall
In order to assess the extent of lymphocytic cellular invasion into the arterial wall, infiltrates in the intimal, medial and adventitial layers were examined. Lymphocytic Ž infiltrates were detected by morphology small oval . mononuclear cells with round nuclei on hematoxylin and eosin stained sections. Lymphocytes were seen in the Ž . medial and adventitial layers Fig. 2C, Fig. 3A more often than in the intimal layers. Care had to be taken to distinguish nucleated erythrocytes from lymphocytes, but these cells can be differentiated by the characteristic erythrocyte cellular shape with pointed ends and the distinctive red pigmentation of the erythrocyte. In the intimal layer cellular adhesion to the endothelial surface was seen more Ž frequently than actual invasion in the intimal layer Ž . CD after treatment with either saline control or pravastatin are shown 82 arterial specimens from 34 chicks . The mean plaque areas were measured on arterial specimens taken from chicks treated for 60 days or more with either saline or pravastatin. Panel B, scattergraph demonstrating the mean plaque Ž area for arterial specimens taken from MDV infected birds and the corresponding lifespan and duration of treatment in Study 2 95 arterial specimens from . 44 chicks that survived past the start of the treatment at 3 months of age . An increase in plaque area becomes apparent in the saline control treated birds Ž . after 60 days treatment. Circle, control saline; diamond, pravastatin; triangle, quinapril. Panel C, Bar graphs of the mean area"S.E. of intimal dotted bar ; Ž . Ž . Ž . medial striped bar and adventitial crossed bar infiltration in the arterial wall in chicks in Study 2 after treatment all treatment times with either control saline, pravastatin, or quinapril. Intima, dotted bar; media, striped bar; adventitia, crossed bar. Panel D, bar graphs are shown demonstrating that there is no Ž detectable significant difference in the area of lymphocyte infiltration shown as mean "S.E. in any of the organs examined 26 liver, 21 kidney, 21 . Ž . Ž myocardium, or 20 peripheral nerve sections after treatment with saline, pravastatin, or quinapril treatment. M, myocardium solid bar ; L, liver right . Ž . Ž . striped bar ; K, kidney crossed bar ; N, nerve left striped bar .
There was no correlation detected between plaque growth and lymphocytic invasion in the arterial wall in any of the layers in either study when assessing all specimens or after assessment of groups treated for less than 60 days Ž . or for 60-90 days with either drug Fig. 2C . The mean area of infiltrate in the intima, media, and adventitia respectively after 60 to 90 days treatment was 0.035 " 0013 mm 2 Fig. 3A . 
Marek's disease Õirus associated lymphoma deÕelop-ment
Typical cellular infiltrates were seen in the liver, kidney, myocardium, and femoral nerves of the chicks in Study 2. The size of the lymphocytic infiltrates was similar in all the birds both prior to and after treatment with either Ž .Ž pravastatin or quinapril in the myocardium Fig. 3B There was also no significant difference in lymphocyte infiltration in any of the organs examined whether the duration of treatment was less than 60 days or for 60-90 Ž days confirmed by blinded analysis by a veterinary . pathologist, data not shown .
Cholesterol leÕels
In a previously reported pilot study, the development of MDV associated plaque was examined and correlated with w x arterial wall cholesterol levels 48,49 . Aortic specimens from infected birds fed a normal poultry diet had a demonstrated increase in cholesterol levels but not in triglyceride w x when corrected for total protein 47,49 . This result is consistent with prior work where an increase in cellular cholesterol levels was reported with MDV infection.
Ž . In the initial pravastatin study Study 1 serum cholesterol levels were measured in the roosters on normal poultry diet and high cholesterol diet. The serum choles-Ž terol was higher in the cholesterol fed roosters 15.2 . mgrdl and was reduced by pravastatin in the cholesterol Ž . fed birds 9.6 mgrdl , as expected, but not in the birds on Ž a normal poultry diet 1.3 mgrdl for both saline and . pravastatin treated chicks . 
Mortality
Ž . In the first study 6r7 85.7% of the cholesterol fed chicks treated with saline died after three months treat-Ž . ment. 4r11 63.6% of the chicks treated with pravastatin on high cholesterol diet died in the same three-month Ž . Ž . treatment period p s 0.055 . 8r8 100% of the chicks in Ž . the saline treated and 4r8 50% of pravastatin treated chicks on normal poultry diets died during the three months Ž . Ž . of treatment Fig. 4A p -0. 02 . Taken together, e.g. both birds fed a normal diet or cholesterol fed, this represents an overall 36% reduction in mortality in pravastatin treated rooster chicks whether fed cholesterol or normal Ž diets average mortality for control treatment was 92.9%, . average mortality for pravastatin treated chicks was 56.8%
Ž
. 4B . The fact that there was no overall effect on mortality on comparison of pravastatin treatment and controls in Study 2 indicates that the initially observed decrease in mortality with pravastatin treatment in Study 1 was not reproduced in the second study.
Discussion
Although viral infections have been implicated in the development of atherosclerosis, the extent to which viral infections alter atherosclerotic plaque growth and the effects of viral infection on vascular responses to anti-atherogenic agents are not known. We have detected significant Ž . reductions in plaque growth Figs. 1-3 in a model of Marek's disease virus infected, cholesterol fed chicks after treatment with both a HMGCoA reductase inhibitor, Ž pravastatin, and an ACE inhibitor, quinapril Figs. 1 and .
.
The results of this study indicate that these two drugs were able to inhibit plaque growth in cholesterol fed roosters in the presence of a prior viral infection known to induce atherosclerosis development. The use of a high cholesterol diet to speed development of atherosclerotic lesions prevents, however, analysis of the relative contributions of viral infection and hypercholesterolemia in plaque growth and its treatment. MDV infection produces a severe and extensive lymphocytic invasion of multiple organs as well as the arterial w x vasculature 17-19 . An analysis of the effects of pravastatin and quinapril on lymphocytic cellular invasion did not reveal a correlation between treatment and plaque formation. However, an inhibition of monocyte or lymphocyte cellular activation acting as an early stimulus to cellular invasion and proliferation cannot be excluded. Both the HMGCoA reductase inhibitors and the ACE inhibitors have been demonstrated to alter leukocyte, specifically monocytermacrophage, activation, albeit by differing mechanisms. The HMG CoA reductase inhibitors have been postulated to reduce monocyte and smooth muscle cellular invasion of the intima, potentially by reducing lipid oxidation products and macrophage activation w x 50 . Pravastatin has, however, no reported effect on smooth muscle cellular or lymphocyte migration or proliferation. The most likely mechanism for the reduction in plaque size seen with pravastatin treatment is therefor a reduction of serum cholesterol levels. ACE inhibitor therapy with quinapril has been demonstrated to improve endothelial w x dysfunction in patients with coronary artery disease 32 and to reduce intimal hyperplasia in several animal models w x of atherosclerosis 33,35-37,40,51 . Other ACE inhibitors, w x w x w x Captopril 37 , fosinopril 37 , perindopril 36 , and cilazaw x pril 35 , have been reported to reduce the accumulation of macrophages in the intima of hypercholesterolemic and hypertensive animal models. Cilazapril has also been found to decrease smooth muscle cellular proliferation after balw x loon injury of the rat carotid artery 35 . This study has also allowed us to examine the validity of Marek's disease virus infection in cholesterol fed roosters as a model for accelerated virus-induced atherosclerosis development. MDV infection is one of the few well characterized models of virus induced atherosclerosis producing an accelerated atherogenic process in the larger arterial branches and the aorta. We have detected reproducible atherosclerotic plaque development in this model with associated extensive foam cell formation and lymphocytic infiltrates. We have also detected significant decreases in plaque growth in this avian model with the administration of a HMGCoA reductase inhibitor and an ACE inhibitor indicating similar responses as seen with prior studies in mammalian models and clinical trials. There remain, nevertheless, concerns inherent in the use of this model, specifically the use of cholesterol feeding to accelerate plaque growth, the presence of an invasive lymphoma with associated high mortality, and the physiologic differences present in avian and mammalian models.
Cholesterol feeding is used to increase the rate and extent of plaque growth in MDV infected chicks, as origiw x nally reported by Fabricant et al. 17, 19, 21 . Previous reports on models of balloon injury and cholesterol feeding w x in White Leghorn roosters 48 , as well as a study comparing virus infected rooster chicks with non-infected chicks w x 49 have shown that cholesterol diet alone produces a much reduced atherosclerotic plaque development on comparison with viral infection or balloon injury combined w x with a high cholesterol diet 48,49 . The initiation of atherosclerotic plaque growth by both virus infection and cholesterol diet, although necessary for rapid production of plaque, does however make differentiation of the effects of cholesterol diet and viral infection difficult, as with most currently used balloon injury models. HMGCoA treatment, pravastatin in this study, most likely reduced plaque growth w x through a reduction in serum cholesterol 50 . Quinapril ) has been found to reduce serum cholesterol levels in w x hyperlipidemic patients 52 which may decrease macrophage activation. The doses of quinapril used in this study were low on comparison with this clinical study, but reduction in serum cholesterol and thus monocyte activation cannot be excluded as the mechanism by which quinapril decreased atheroma development.
HMGCoA reductase inhibitors, simvastatin, pravastatin and lovastatin, have been reported to decrease mortality as well as the number of cardiac events in patients with w x moderate to high serum levels of cholesterol 26-29 . Pravastatin reduces episodes of cardiac rejection, ischemic heart disease, incidence of coronary vasculopathy, and w x mortality in cardiac transplant patients 30 . ACE inhibitors reduce the incidence of myocardial infarction and mortalw x ity in patients with low ejection fractions 33,34 . This ACE inhibitor associated reduction in mortality may be in part due to reduced atherosclerotic plaque growth that has w x been detected after balloon induced intimal injury [35] [36] [37] [38] [39] w x and after transplant 40 in animal models. ACE inhibitor treatment has also been demonstrated to reduce transplant w x vasculopathy in preliminary clinical trials 40 . We have detected a reduction in plaque growth in MDV infected chicks, but no reproducible reduction in mortality. Thus this model only partially mirrors the effects of these drugs as reported in clinical trials. The invasive lymphoma seen in MDV infection has an associated high mortality which may alter vascular responses and therapeutic efficacy and may prevent the detection of a reduction in mortality associated with the decreased atherosclerosis development produced by each drug. The effects of each drug on atherosclerotic plaque growth might also be attributed to differences in the intensity of viral infection and comorbidity, or the length of time individual chicks were treated. In order to control for variations in viral infectivity and disease severity, these studies were randomized for treatment. An initially higher dose of quinapril appeared to have an adverse effect on the MDV infected chicks and Ž . did increase mortality significantly p -0.003 . After the quinapril dose was reduced the side effects were diminished and the initial increased mortality was immediately reversed with the lower dose as seen in the survival curve Ž . Fig. 4B .
Avian models differ physiologically from mammalian models in that the erythrocytes are nucleated and the platelets more closely resemble megakaryocytes and are w x again nucleated 53 . The atherosclerotic plaque that develw x w x ops after balloon injury 47 , MDV infection 17-19,21 , or in cholesterol fed roosters, however, resembles human atheroma in that a wide range of plaque composition is seen with fatty, fibrotic, calcific and thrombotic areas in w x some avian models 48,49 . MDV infection in cholesterol fed rooster chicks may provide a valid model for the study of virus associated injury and atherogenesis, but further studies will be necessary to clarify the relative contributions of viral infection and hypercholesterolemia to plaque development in this model. This study indicates that HMGCoA reductase inhibitors and ACE inhibitors should be considered for further study as adjunctive therapy for transplant associated accelerated atherosclerosis development. 
